MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 60 filers reported holding MARKER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $98,766 | +43.1% | 374,964 | +100.0% | 0.00% | – |
Q3 2022 | $69,000 | +11.3% | 187,482 | 0.0% | 0.00% | – |
Q2 2022 | $62,000 | -25.3% | 187,482 | -1.1% | 0.00% | – |
Q1 2022 | $83,000 | -55.6% | 189,482 | -3.6% | 0.00% | – |
Q4 2021 | $187,000 | -43.7% | 196,651 | 0.0% | 0.00% | – |
Q3 2021 | $332,000 | -38.3% | 196,651 | +2.0% | 0.00% | – |
Q2 2021 | $538,000 | -58.3% | 192,751 | -66.5% | 0.00% | – |
Q1 2021 | $1,291,000 | +64.7% | 576,225 | +6.6% | 0.00% | – |
Q4 2020 | $784,000 | -7.1% | 540,604 | -3.9% | 0.00% | – |
Q3 2020 | $844,000 | -23.0% | 562,503 | +6.2% | 0.00% | – |
Q2 2020 | $1,096,000 | -0.6% | 529,671 | -8.8% | 0.00% | – |
Q1 2020 | $1,103,000 | -32.8% | 580,677 | +1.9% | 0.00% | – |
Q4 2019 | $1,642,000 | -41.0% | 569,995 | +4.7% | 0.00% | – |
Q3 2019 | $2,782,000 | -29.4% | 544,503 | +9.4% | 0.00% | – |
Q2 2019 | $3,941,000 | +2715.0% | 497,578 | +2247.1% | 0.00% | – |
Q1 2019 | $140,000 | +18.6% | 21,200 | 0.0% | 0.00% | – |
Q4 2018 | $118,000 | – | 21,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |